RxDoctor Payments Data

Atur Patel, MD

Otolaryngology · Greenbelt, MDNPI 1689036683

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,628, 4.5 times the $358 reported in 2021.

$6,057in general payments, 2019–2025

Across 279 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Jazz Pharmaceuticals Inc.$763
  • Inspire Medical Systems, Inc.$732
  • Axsome Therapeutics, Inc.$726
  • Optinose US, Inc.$702
  • Regeneron Healthcare Solutions, Inc.$537
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$1192%
  • Food & beverage$5,83896%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,057 in reported general payments places this provider in the 85th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$240,801
Medicare patients
619
Services billed
8,831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl62$2,698
Fluticasone Propionate84$2,303
Fluocinolone Acetonide Oil16$913
Ipratropium Bromide27$888
Omeprazole20$548
Famotidine16$437
Mupirocin13$186
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$181

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Greenbelt

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →